Quantitative Radiology is now part of AFP Imaging. Purchase of the Italian firm, which has installed about 500 conebeam CT scanners for dental applications over the past decade, is being framed as a coup by AFP chairman and cofounder David Vozick.
Quantitative Radiology is now part of AFP Imaging. Purchase of the Italian firm, which has installed about 500 conebeam CT scanners for dental applications over the past decade, is being framed as a coup by AFP chairman and cofounder David Vozick.
AFP paid €13 million, or about $17.2 million, for Quantitative, about just six times earnings before interest, taxes, depreciation, and amortization, according to Vozick, who described the deal as fair.
"This is really a coup," he said. "A lot of deals go for more than six times EBITDA."
Behind the deal is a family of scanners called NewTom, which have been cleared for sale in the U.S., Europe, and other parts of the world. The Italian company recently added a new version called the Vertical Generation. Unveiled at two major dental trade shows earlier this year, NewTom VG, which is mounted on a vertical stand, allows the patient to be scanned while standing or sitting, rather than lying down.
Quantitative Radiology builds the systems in Verona and distributes the product globally through dealers and other contracted firms. Most NewTom users are dentists, implantologists, oral surgeons, and orthodontists, as well as some ear, nose, and throat specialists. They make up an annual global market for such CTs of about $100 million, according to AFP.
For the past year, AFP has been the exclusive distributor of NewTom in North America. Now, with a firm grip on the company and its product development, Vozick plans to expand the reach of this technology.
"The Italian company did not aggressively pursue the nondental markets," Vozick said.
"We will."
AFP is represented in the ENT marketplace by Gyrus under a nonexclusive distribution agreement. It will also position NewTom in dentistry for what Vozick describes as the coming age of robotic surgery.
"There is going to be robotic dentistry just as we have robotic surgery in hospitals," he said.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.